News

In Breast Cancer Metastasis, Researchers Identify Possible Drug Target

In Breast Cancer Metastasis, Researchers Identify Possible Drug Target

January 28, 2013

The spread of breast cancer to distant organs within the body, an event that often leads to death, appears in many cases to involve the loss of a key protein, according to UC San Francisco researchers, whose new discoveries point to possible targets for therapy.

Making Health Care Research More Relevant

Making Health Care Research More Relevant

January 23, 2013

Nearly 100 UCSF faculty and staff turned out on January 8th for a Comparative Effectiveness Research (CER) and Patient-Centered Outcomes Research (PCOR) symposium hosted by the Comparative Effectiveness Research program at UCSF's Clinical and Translational Science Institute (CTSI).

Scientific Community at Mission Bay Fosters Research Breakthroughs

Scientific Community at Mission Bay Fosters Research Breakthroughs

January 23, 2013

With UCSF Mission Bay gleaming brighter every day, it's easy to forget a time when some UCSF researchers did not want to leave the hive of activity on the Parnassus Heights campus for entirely new labs across town in a once-forsaken neighborhood.

On Mission Bay's 10th Anniversary, Hospital Construction Surges Forward

On Mission Bay's 10th Anniversary, Hospital Construction Surges Forward

January 23, 2013

Ten years after the UCSF Mission Bay campus was established, UCSF Medical Center at Mission Bay – the key patient-care component of the campus – is only two years away from opening. Construction of the 289-bed state-of-the-art hospital complex for children, women and cancer patients is moving along swiftly, on schedule and on budget.

Campus Technology Centers Receive $2 Million

Campus Technology Centers Receive $2 Million

January 15, 2013

Ten core facilities on campus have been selected to receive a collective $2 million in funds from the Chancellor’s office to expand and improve access to transformative research technologies across UCSF. 

 

 

Drug-Resistant Melanoma Tumors Shrink When Therapy Is Interrupted

Drug-Resistant Melanoma Tumors Shrink When Therapy Is Interrupted

January 9, 2013

Researchers in California and Switzerland have discovered that melanomas that develop resistance to the anti-cancer drug vemurafenib (marketed as Zelboraf), also develop addiction to the drug, an observation that may have important implications for the lives of patients with late-stage disease.